Many people throughout the UK are dealing with a puzzling and severe skin disorder that has left the medical profession baffled. Sufferers experience their skin badly inflamed, cracked and flaking, often across their entire bodies, yet many doctors find it difficult to diagnose and treat the condition. The phenomenon, called topical steroid withdrawal (TSW) or red skin syndrome, has sparked unprecedented interest on social media, with footage showing patients’ experiences accumulating over one billion views on TikTok alone. Despite affecting a increasing number of people, TSW remains so poorly understood that some GPs and skin specialists query whether it actually exists at all. Now, for the very first time, researchers across the UK are undertaking a large-scale study to examine what is causing these unexplainable symptoms and how some people come to develop the condition while others remain unaffected.
The Unexplained Condition Spreading Across the UK
Bethany Gamble’s story exemplifies the devastating impact of topical steroid withdrawal on patients’ wellbeing. The 21-year-old from Birmingham had managed her eczema well with steroid creams since childhood, but at eighteen, her condition took a dramatic turn for the worse. Her skin became severely inflamed and reddened, breaking and leaking whilst the itching became what she characterises as “bone deep”. Within two years, the pain had become so intense that she was stuck in her bed, needing constant care from her mother. Most concerning, Bethany experienced repeated dismissal by healthcare providers who ascribed her symptoms to standard eczema and kept prescribing the very treatments she thought were responsible for her suffering.
The medical establishment remains divided on how to approach TSW, with fundamental disagreement about its basic nature. Some experts view it as a severe allergic response to the topical steroids that represent the standard treatment for eczema across the NHS. Others maintain it represents a serious exacerbation of pre-existing skin conditions rather than a separate syndrome, whilst a handful doubt of its existence. This professional uncertainty has left patients like Bethany trapped in a diagnostic uncertainty, finding it hard to obtain suitable treatment. The lack of consensus has led Professor Sara Brown at the Edinburgh University to set up the first significant UK research initiative investigating TSW, funded by the National Eczema Society.
- Symptoms comprise severe inflammation, cracking skin and intense itching across the body
- Patients report “elephant skin” thickening and extreme shedding of dead skin cells
- Medical professionals frequently overlook TSW as typical dermatitis or refuse to acknowledge it
- The condition may prove so incapacitating that sufferers become unable to perform daily activities
Living with Steroid Topical Withdrawal
From Manageable Eczema to Severe Symptoms
For numerous patients, withdrawal from topical steroids constitutes a catastrophic deterioration from a previously stable dermatological condition. What begins as intermittent itching in skin creases can rapidly escalate into a full-body inflammatory response that leaves patients unable to function. The change typically happens suddenly, without warning, transforming a manageable chronic condition into an severe medical emergency. Patients report their skin becoming impossibly hot, inflamed and red, with severe cracking and weeping that demands ongoing care. The bodily burden is worsened by exhaustion, as the persistent itching prevents sleep and recovery, creating a destructive cycle of decline.
The rate at which TSW unfolds catches many sufferers by surprise. Those who have lived with eczema for years, sometimes decades, are unprepared for the magnitude of symptoms that appear when their condition rapidly deteriorates. Everyday tasks become overwhelming difficulties: showering becomes excruciating, dressing demands help, and keeping clean demands substantial energy. Some patients recount feeling as though their skin is under assault from within, with inflammation moving through their body in patterns that show little similarity to their previous eczema flare-ups. This striking change often leads sufferers to obtain emergency care, only to face doubt from healthcare professionals.
The Fight for Recognition
Perhaps the cruelest aspect of topical steroid withdrawal is the medical gaslighting that commonly occurs with it. Patients experiencing serious, unexplained health issues are consistently informed they merely suffer from eczema worsening, despite their insistence that this is essentially distinct from anything they’ve experienced before. Doctors frequently react by prescribing stronger steroids or increased doses, potentially worsening the very condition patients believe the creams caused. This pattern of rejection leaves sufferers feeling abandoned by the healthcare system, compelled to manage their illness alone whilst being told their lived experience is invalid. Many patients report feeling gaslit repeatedly, their concerns dismissed as anxiety or psychological rather than actual physical health issues.
The lack of medical consensus has created a dangerous gap between patient experience and professional recognition. Without established diagnostic standards or defined treatment approaches, general practitioners and skin specialists struggle to identify TSW or offer appropriate support. Some practitioners remain completely sceptical the disorder is real, treating all acute cases as standard eczema or recognised skin disorders. This clinical doubt results in diagnostic delays, inappropriate treatment and profound psychological distress for people experiencing physical symptoms. The increased prominence of TSW on social media has drawn attention to this diagnostic gap, encouraging investigation to investigate what thousands of people claim to be experiencing, even as the healthcare profession remains divided on the appropriate response.
- Signs may develop suddenly in people with formerly controlled eczema managed by topical steroids
- Patients frequently encounter scepticism from healthcare professionals who attribute worsening to standard eczema flares
- Medical professionals remain divided on whether TSW is a real disorder or acute eczema flare-up
- Lack of diagnostic criteria means numerous patients struggle to access suitable care and assistance
- Online platforms has magnified patient voices, with TSW hashtags accumulating more than one billion views worldwide
Racial Disparities in Diagnostic and Treatment Pathways
The diagnostic difficulties surrounding TSW become even more pronounced amongst those with darker complexions, where symptoms can be substantially more challenging to detect visually. Erythema and inflammatory responses, the defining features of TSW in people with lighter skin, appear differently across multiple populations, yet many clinical guidelines remain focused on how the condition appears in white patients. This difference means that individuals from Black, Asian and minority ethnic backgrounds experiencing TSW commonly experience even greater delays in recognition and validation. Clinical practitioners trained mainly through manifestations in lighter-skinned individuals may fail to recognise the typical indicators, causing continued misidentification and unsuitable therapeutic suggestions that can worsen symptoms.
Research into TSW has traditionally overlooked the experiences of people with deeper skin tones, sustaining a pattern where their symptoms remain insufficiently documented and inadequately researched. The social media conversations dominating TSW discussions have been largely shaped by individuals with lighter complexions, potentially skewing medical understanding and community understanding. As Professor Sara Brown’s groundbreaking UK study progresses, ensuring diverse representation amongst research participants will be crucial to developing truly inclusive diagnostic frameworks and therapeutic strategies. Without intentional action to prioritise the perspectives of diverse populations, healthcare disparities in TSW recognition and management risk widening further, abandoning at-risk communities without adequate support or answers.
| Skin Tone | TSW Appearance |
|---|---|
| Light/Fair | Bright red inflammation, visible flushing and erythema across affected areas |
| Medium/Olive | Darker red or brownish discolouration with less pronounced visible redness |
| Dark/Deep | Purple-toned or ashen discolouration, with inflammation appearing as hyperpigmentation or hypopigmentation |
| Very Dark | Subtle changes in skin texture and tone, with inflammation manifesting as dark patches or loss of pigmentation |
Treatment and Research Approaches Emerging
Initial Major UK Investigation In Progress
Professor Sara Brown’s landmark research at the Edinburgh University constitutes a watershed moment for TSW sufferers seeking validation and comprehension. Funded by the National Eczema Society, the study has brought together numerous participants across the UK to explore the physiological processes behind topical steroid withdrawal. By assessing symptoms, saliva samples and skin biopsies, researchers aim to identify why some people exhibit TSW whilst others using identical steroid regimens do not. This rigorous investigation marks a significant shift from dismissal to rigorous examination.
The study team partnering with Dr Alice Burleigh from patient advocacy group Scratch That, brings both medical knowledge and personal experience to the research. Their collaborative approach accepts that patients themselves hold crucial insights into their conditions. Professor Brown has identified patterns in TSW that cannot be accounted for by standard eczema knowledge, including marked “elephant skin” thickening, extreme shedding and sharply demarcated zones of inflammation. The research findings could significantly transform how medical professionals manage diagnosis and treatment of this debilitating condition.
Treatment Options and Their Limitations
At present, management options for TSW remain limited and commonly disappointing. Many medical practitioners persist in prescribing topical steroids notwithstanding evidence implying they might intensify symptoms in those predisposed. Some patients note transient relief from emollients, antihistamines and oral medications, though responses vary considerably. Dermatologists remain divided on most effective management plans, with some supporting total steroid discontinuation whilst others advocate phased withdrawal. This absence of agreement sees patients managing their therapeutic pathways predominantly by themselves, depending significantly on peer support networks and digital communities for direction.
Psychological assistance with specialist dermatological care may provide advantages, yet access remains patchy across the NHS. Some patients have explored alternative approaches including dietary modifications, managing environmental factors and whole-person treatment approaches, though scientific evidence supporting these interventions is limited. The absence of established clinical protocols means treatment decisions often depend on individual dermatologist experience and patient preference rather than research-informed standards. Until robust research produces definitive answers, TSW sufferers frequently describe feeling abandoned by conventional medicine.
- Emollient creams and hydrating products to support skin barrier function and minimise water loss
- Antihistamines to control itching and associated sleep disruption in flare episodes
- Oral corticosteroids or immunosuppressants for serious presentations with specialist oversight
- Therapeutic counselling to address emotional distress and worry stemming from prolonged skin suffering
Testimonies of Aspiration and Perseverance
Despite the uncertainty regarding TSW and the often dismissive attitudes from medical practitioners, patients are gaining resilience in shared community and shared experience. Digital support communities have proven vital for those struggling with the condition, offering practical guidance and validation when traditional medicine has let them down. Many individuals affected recount the point at which they found the TSW hashtag as transformative—finally connecting with others with the same symptoms and recognising they were not alone in their experience. This collective voice has been powerful enough to spark the initial serious research initiatives, showing that patient-led campaigns can drive medical progress even when established institutions stay unconvinced.
Bethany Gamble and people in similar situations are determined to increase visibility and push for appropriate acknowledgement of TSW within the medical establishment. Their readiness to recount personal stories of their difficulties on online platforms has made discussions more commonplace around a condition that many doctors still refuse to acknowledge. These people are not sitting idly for responses; they are taking part in clinical trials, tracking their signs thoroughly, and demanding that their accounts be taken seriously. Their fortitude in the face of ongoing pain and medical gaslighting offers hope that answers may finally be within grasp, and that those to come will receive the acknowledgement and treatment they so desperately need.
- Patient-led research initiatives are filling gaps left by conventional healthcare systems and accelerating understanding of TSW
- Digital support networks offer emotional support, practical coping strategies, and peer validation for isolated sufferers globally
- Advocacy efforts are gradually shifting clinical attitudes, prompting dermatologists to examine rather than dismiss individual accounts
